Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5900 Patients from Israel.

AS patients had increased mortality risk compared to the general population after adjusting for age, sex, and baseline comorbidities.AS patients treated with TNFi did not demonstrate excess mortality compared to matched controls.Within the AS cohort age, male-gender, background comorbidities, and higher CRP levels were identified as risk factors for mortality.